Action ATTBF ABATTIS BIOCEUTICALS CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Abattis Bioceuticals Corp.

Actions

ATTBF

CA00258G1037

Temps Différé OTC Markets
Autres places de cotation
 15:30:05 26/06/2024 		Varia. 5j. Varia. 1 janv.
0,000001 USD 0,00% Graphique intraday de Abattis Bioceuticals Corp. 0,00% 0,00%
2018 Abattis Bioceuticals Corp. fournit des prévisions de revenus pour le quatrième trimestre 2018. CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
PR
Abattis Bioceuticals : Signs LOI With Kanabé to Provide a Full Suite of Downstream Cannabis Solutions to Their Premium Health and Wellness Products
PR
Abattis Bioceuticals : Explores Diversifying with a Strategic Acquisition -- CFN Media
MW
Abattis Announces An Independent Valuation On Green Nature Health Care Products
NE
Abattis Bioceuticals : ATTBF) Northern Vine Labs and the New Canadian Rules -- CFN Media
MW
Abattis Issues Common Shares
NE
Abattis Provides Corporate Update
NE
Abattis Announced Private Placement Agreement of Up To $5,000,000
NE
Abattis Bioceuticals : (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media
MW
Abattis Issues Shares and Units
NE
Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China
NE
Abattis Announces Licensing Deal and Brand Acquisition Between Vergence and Green Nature Health Care Products Inc., of China
NE
Abattis Announces Renewal of Health Canada Licence
NE
Abattis Announces the Appointment of New Independent Director
NE
Abattis Bioceuticals : ' Federally Licensed Lab and the Crucial Role It Plays -- CFN Media
MW
Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc.
NE
Abattis Issues Common Shares
NE
Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
MW
Abattis Bioceuticals Corp.: Experion Biotechnologies Prepares for Construction
NE
Abattis Signs MOU with Global Damon Pharma of South Korea
NE
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ATTBF
  4. Actualités Abattis Bioceuticals Corp.
  5. Communiqués